(Q33643154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Griebel G

series ordinal

1

1 reference

28 July 2017

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology & Therapeutics

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

The effects of CRF and α-helical CRF on anxiety in normal and hypophysectomized rats

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The effects of corticotrophin releasing factor (CRF) and handling stress on behavior in the elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y in human spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

1 reference

7 January 2021

Further characterization of the behavioral effects of peripherally administered corticotropin-releasing factor in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiogenic activity of isatin, a putative biological factor, in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Radioautographic localization of 125I-atrial natriuretic factor binding sites in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Structure-activity studies on the effects of atrial natriuretic peptide, brain natriuretic peptide and their analogs on fear-motivated learning behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Involvement of neurotransmitters in the 'anxiolytic-like' action of atrial natriuretic peptide in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effect of receptor blockers on brain natriuretic peptide and C-type natriuretic peptide caused anxiolytic state in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Elevated plasma levels of neuropeptide Y in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Two faces of cholecystokinin: anxiety and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Central effects of corticotropin releasing factor (CRF): evidence for similar interactions with environmental novelty and with caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiolytic activity of NPY receptor agonists in the conflict test

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of corticotropin-releasing factor, corticotropin and cortisol on gastrointestinal motility in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Evidence for the involvement of corticotropin-releasing factor in the gastrointestinal disturbances induced by acoustic and cold stress in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiolytic effects of CCK-B antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y: regional distribution chromatographic characterization and immunohistochemical demonstration in post-mortem human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Open-field bheavior in the rat: what does it mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Immunochemical evidence of cholecystokinin-like peptides in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor has an anxiogenic action in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Distribution of cholecystokinin-like peptides in the human-brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Cholecystokinin enhances the acoustic startle response in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates the expression of fear-potentiated startle in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Intracerebroventricular infusion of the CCKB receptor agonist pentagastrin potentiates acoustic startle.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

1 reference

7 January 2021

Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Isatin is a potent endogenous antagonist of guanylate cyclase-coupled atrial natriuretic peptide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effect of intracerebroventricular administration of alpha-helical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Predator-elicited flight responses in Swiss-Webster mice: an experimental model of panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Central nervous system characterization of the new cholecystokininB antagonist LY288513.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Peripherally administered CRH suppresses the vocalizations of isolated guinea pig pups

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of centrally administered corticotropin-releasing factor (CRF) and alpha-helical CRF on the vocalizations of isolated guinea pig pups

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Evidence that endogenous corticotropin-releasing factor suppresses behavioral responses of guinea pig pups to brief isolation in novel surroundings

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Synthesis and relative potencies of new constrained CRF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Cloned human neuropeptide Y receptor couples to two different second messenger systems

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Distribution of cholecystokinin-like immunoreactivity in the nervous system. Co-existence with classical neurotransmitters and other neuropeptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Microinfusion of corticotropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Presence of avian pancreatic polypeptide-like immunoreactivity in catecholamine and methionine-enkephalin-containing neurones within the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Isolation and amino acid sequence of urotensin I, a vasoactive and ACTH-releasing neuropeptide, from the carp (Cyprinus carpio) urophysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Distinct cholecystokinin receptors in brain and pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Central administration of corticotropin releasing factor alters rat pup isolation calls

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CSF corticotropin-releasing factor is not affected in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The CCKB antagonist, L-365,260, attenuates fear-potentiated startle.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor administered intraventricularly to rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CRF antagonist partially reverses CRF- and stress-induced effects on feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of 5-HT-1A receptor agonists on CRF-induced behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Stress and corticotropin-releasing factor potentiate center region activity of mice in an open field.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Role of the septum in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y and sympathetic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiogenic behavior in the light-dark paradigm follwoing intraventricular administration of cholecystokinin-8S, restraint stress, or uncontrollable footshock in the CD-1 mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The mammalian tachykinin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Peripheral administration of a corticotropin-releasing factor antagonist increases the vocalizing and locomotor activity of isolated guinea pig pups

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effect of central and peripheral administrations of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Two brain cholecystokinin receptors: implications for behavioral actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Urocortin, a novel neuropeptide with anxiogenic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotrophin releasing factor, grooming and ingestive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Flumazenil blockade of anxiety following ethanol withdrawal in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Hormonal polypeptides of the upper intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y produces anxiety via Y2-type receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Minisymposium: the natriuretic peptide hormones. Introduction. Editorial and historical review

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neurotransmitter functions of mammalian tachykinins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Repeated stress, like vasopressin, sensitizes the excitatory effects of corticotropin releasing factor on the acoustic startle reflex.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Behavioral effects of atriopeptin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Stress and emotionality: a multidimensional and genetic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Cortical 5-HT-CCK interactions and anxiety-related behaviour of guinea-pigs: a microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Animal models of ??anxiety??: where next?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

ICV-CRH potently affects behavior without altering antinociceptive responding.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The effects of ICV-CRH on novelty-induced behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Distribution of atrial natriuretic factor-like immunoreactive neurons in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor acts via a third ventricle site to reduce exploratory behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Plasma neuropeptide Y in anxiety disorders: findings in panic disorder and social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CRH overproduction in transgenic mice: behavioral and immune system modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Central and peripheral administration of atriopeptin is anxiolytic in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin releasing factor produces behavioural activation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Alcohol reverses the proconflict effect of corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Cholecystokinin in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Differential behavioral actions of corticotropin-releasing factor (CRF)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Isatin, regional distribution in rat brain and tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing hormone modulation of a conditioned stress response in the central amygdala of Roman high (RHA/Verh)-avoidance and low (RLA/Verh)-avoidance rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Biological effects of rat iso-atrial natriuretic peptide and brain natriuretic peptide are indistinguishable from each other.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

CRH and alpha-helical-CRH modulate behavioral measures of arousal in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Antisense oligonucleotides to corticotropin-releasing factor impair memory retention and increase exploration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Central beta 1-adrenergic receptors are involved in CRF-induced defensive withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

The substance P (NK1) receptor antagonist (±)-CP-96,345 causes sedation and motor impairment in Swiss albino mice in the black-and-white box behavioral paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Interactions of corticotropin-releasing factor with antidepressant and anxiolytic drugs: behavioral studies with pigeons.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Effects of peripherally administered corticotropin-releasing factor (CRF) and a CRF antagonist: does peripheral CRE activity mediate behavior of guinea pig pups during isolation?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

Corticotropin-releasing factor antagonist attenuates defensive-withdrawal behavior elicited by odors of stressed conspecifics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900041-2

7 January 2021

10.1016/S0163-7258(98)00041-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10341356%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference